Brachman D - Search Results

1

A dosimetric study comparing three-, four-, and six- field plans for treatment of carcinoma of the prostate.

Haraf DJ, Kuchnir FT, Watson-Bullock S, Brachman D, Doughtery M, Rubin S, Sutton H. Haraf DJ, et al. Among authors: brachman d. Med Dosim. 1992 Winter;17(4):191-8. doi: 10.1016/s0958-3947(05)80003-2. Med Dosim. 1992. PMID: 1485906

2

Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer.

Brachman DG, Graves D, Vokes E, Beckett M, Haraf D, Montag A, Dunphy E, Mick R, Yandell D, Weichselbaum RR. Brachman DG, et al. Cancer Res. 1992 Sep 1;52(17):4832-6. Cancer Res. 1992. PMID: 1324797

3

Two prostate carcinoma cell lines demonstrate abnormalities in tumor suppressor genes.

Rubin SJ, Hallahan DE, Ashman CR, Brachman DG, Beckett MA, Virudachalam S, Yandell DW, Weichselbaum RR. Rubin SJ, et al. Among authors: brachman dg. J Surg Oncol. 1991 Jan;46(1):31-6. doi: 10.1002/jso.2930460108. J Surg Oncol. 1991. PMID: 1986144

4

Cellular and molecular mechanisms of radioresistance.

Weichselbaum RR, Beckett MA, Vokes EE, Brachman DG, Haraf D, Hallahan D, Kufe D. Weichselbaum RR, et al. Among authors: brachman dg. Cancer Treat Res. 1995;74:131-40. doi: 10.1007/978-1-4615-2023-8_7. Cancer Treat Res. 1995. PMID: 7779612 Review. No abstract available.

5

p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines.

Brachman DG, Beckett M, Graves D, Haraf D, Vokes E, Weichselbaum RR. Brachman DG, et al. Cancer Res. 1993 Aug 15;53(16):3667-9. Cancer Res. 1993. PMID: 8339273

6

Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival.

Haraf DJ, Nodzenski E, Brachman D, Mick R, Montag A, Graves D, Vokes EE, Weichselbaum RR. Haraf DJ, et al. Among authors: brachman d. Clin Cancer Res. 1996 Apr;2(4):755-62. Clin Cancer Res. 1996. PMID: 9816227

7

Concomitant 5-FU, hydroxyurea and cisplatin with external beam radiation therapy for locally advanced pancreatic cancer.

Chen L, Haraf D, Brachman D, Vokes E, Schilsky R. Chen L, et al. Among authors: brachman d. Oncol Rep. 1997 Sep-Oct;4(5):877-81. doi: 10.3892/or.4.5.877. Oncol Rep. 1997. PMID: 21590158

8

5-Fluorouracil, hydroxyurea and escalating doses of iododeoxyuridine with concomitant radiotherapy for malignant gliomas: a clinical and pharmacologic analysis.

Vokes EE, Dolan ME, Krishnasamy S, Mick R, Ratain MJ, Berezin F, Brachman D, Whitman G, Schilsky RL, Charette J, et al. Vokes EE, et al. Among authors: brachman d. Ann Oncol. 1993 Aug;4(7):591-5. doi: 10.1093/oxfordjournals.annonc.a058594. Ann Oncol. 1993. PMID: 8395874 Free article. Clinical Trial.

9

Changing face and different countenances of prostate cancer: racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era.

Jani AB, Vaida F, Hanks G, Asbell S, Sartor O, Moul JW, Roach M 3rd, Brachman D, Kalokhe U, Muller-Runkel R, Ray P, Ignacio L, Awan A, Weichselbaum RR, Vijayakumar S. Jani AB, et al. Among authors: brachman d. Int J Cancer. 2001 Dec 20;96(6):363-71. doi: 10.1002/ijc.1035. Int J Cancer. 2001. PMID: 11745507

10

Dosimetric Impacts of Source Migration, Radioisotope Type, and Decay with Permanent Implantable Collagen Tile Brachytherapy for Brain Tumors.

Pinnaduwage DS, Srivastava SP, Yan X, Jani S, Brachman DG, Sorensen SP. Pinnaduwage DS, et al. Among authors: brachman dg. Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221106852. doi: 10.1177/15330338221106852. Technol Cancer Res Treat. 2022. PMID: 35712977 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters